These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 21045640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK, Culler SD, Saini SS, Beck LA, Chen SC.
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S, Ruof J, Huelsemann JL, Mittendorf T, Handelmann S, Mau W, Zeidler H.
    Arthritis Rheum; 2005 Apr 15; 53(2):234-40. PubMed ID: 15818718
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD.
    Neurology; 2008 Jul 01; 71(1):21-7. PubMed ID: 18591502
    [Abstract] [Full Text] [Related]

  • 14. The societal burden of osteoporosis in Sweden.
    Borgström F, Sobocki P, Ström O, Jönsson B.
    Bone; 2007 Jun 01; 40(6):1602-9. PubMed ID: 17433804
    [Abstract] [Full Text] [Related]

  • 15. Clinical and economic burden of pneumococcal disease in older US adults.
    Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA.
    Vaccine; 2010 Jul 12; 28(31):4955-60. PubMed ID: 20576535
    [Abstract] [Full Text] [Related]

  • 16. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
    Sasser AC, Rousculp MD, Birnbaum HG, Oster EF, Lufkin E, Mallet D.
    Womens Health Issues; 2005 Jul 12; 15(3):97-108. PubMed ID: 15894195
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team.
    Pediatrics; 2005 May 12; 115(5):1220-32. PubMed ID: 15867028
    [Abstract] [Full Text] [Related]

  • 18. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY, Tam LS, Lee VW, Lee KK, Li EK.
    Arthritis Rheum; 2009 Sep 15; 61(9):1159-67. PubMed ID: 19714597
    [Abstract] [Full Text] [Related]

  • 19. Considerations in the pharmacoeconomics of dry eye.
    Hirsch JD.
    Manag Care; 2003 Dec 15; 12(12 Suppl):33-8. PubMed ID: 14723112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.